• Abstracts should only be submitted through the website and in English.
  • Opening of portal for abstract submission: 3rd July 2023

  • The presenting author has to be registered in order to submit an abstract.
  • Abstracts must be submitted electronically no later than midnight on 4th October 2023.

  • Only the presenting author can submit an abstract. An abstract submitted by someone else might be refused.
  • Acknowledgement of receipt of the submission will be sent to the e-mail address specified in the registration form.
  • The presenting author will receive all correspondence concerning the abstract and is responsible for informing co-authors of the status of the abstract.
  • In cases where the abstract is NOT accepted, participants will be contacted promptly and the registration fee fully reimbursed.

Abstract selection process

Abstracts submitted for presentation will be reviewed by an international panel of experts.

The submitter will be notified of the acceptance or rejection of the abstract in the first half of November 2023 .

Abstracts can be selected for one or both of the following presentation formats:

  • Oral presentation: The abstract is selected for an oral presentation of 10-12 minutes, in the appropriate session of the congress.
  • Flash Poster: The abstract is selected for a 1,5 minutes oral presentation in main auditorium. 1 slide only.
  • Poster presentation: The abstract is selected for presentation in a poster format. Posters are grouped by topic and are displayed throughout the congress in the dedicated poster room.

Poster size: H = 1.50, W = 0.90M, portrait mode.

If a selected presenting author cannot attend, he/she should assign a substitute and inform the SMA Europe’s Research Manager , [email protected],  of this replacement in due time.

Posters can be viewed by participants during coffee breaks, lunch and poster sessions. Please note that two formal poster sessions have been organised.

All accepted abstracts will be published in the congress book.

In case of queries, please contact our Research Manager, Vanessa Christie-Brown, at: [email protected]


Abstract instructions

  • Abstracts must be written in English
  • Title: maximum 200 characters
  • Maximum 3,000 characters (including spaces but excluding title and author’s contact information)
  • There is a limit of 20 co-authors for each abstract. If additional co-authors have contributed, they should be referred to as a Study Group and can later be displayed on the poster or appropriately be acknowledged during an oral presentation.
  • References and credits should not be included in the abstract, nor subheadings or keywords.
  • Note that all subheadings in abstracts will automatically be removed by the programme committee.
  • It is the author’s responsibility to submit a correct abstract; if accepted, any spelling, grammatical or scientific errors, will be reproduced as typed by the author.
  • Upon submission, please choose one of the following topics that best describes the content of the abstract:
    • Rehabilitation in SMA
    • Developmental Aspects of SMA
    • SMN beyond the Motor Neuron
    • Optimising Gene-directed Therapeutics
    • Immune System Contributions to SMA
    • Muscles in SMA
    • Monitoring Disease Outcomes
    • Other

Format for submission:

  • Registration reference number
  • Title:  maximum 200 characters
  • Content: maximum 3,000 characters
  • Author: title, name and e-mail address, institution (e.g. university, industry)
  • Co-authors: maximum 20

Download the adequate abstract template here.
Please find more submission guidelines here.